Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Research and Innovation Action · Running

EPoCA Empowering Africa's Point of Care with Cutting-edge Graphene Biosensing for Rapid Detection and Interconnected Surveillance of Novel Ebola Virus Outbreaks.

Coordinator
Libelium Comunicaciones Distribuidas SL, Spain
Runs
1 July 2024 to 30 June 2027
Status
Running
EU funding
€2.9m
Total cost
€2.9m
Partners
8 organisations in 5 countries
Type
Research and Innovation Action
Grant agreement
101145795

What the project is doing

In the project's own words, from its summary on CORDIS.

This project proposes developing, preclinical and clinical validation of a Point of Care (PoC) biosensing platform based on multiplexed field-effect sensor technology based on graphene monolayers functionalized with specific and oriented recognizing biomolecules (BioGFET). This technology will be used for the rapid and remote diagnosis of Ebola infection by titrating specific biomarkers in peripheral blood samples. To strengthen the diagnostic ability and offer a robust differential triage of patients, serological biomarkers specific for the virus and biomarkers specific for infection severity will be analyzed and compared simultaneously (Figure).

Therefore, the final correlation between the achieved parameters will offer a robust and rapid triage of patients, thus, permitting to identify rapidly at the point-of-care potential Ebola outbreaks and offering to physicians a more precise overview of the patient status before knowing the confirming laboratory results. Besides the proposed technology, another key point of this device is represented by its IA-based cloud networking.

In fact, once processed and retrieved, the locally achieved diagnostic results will be transmitted to a central server (for example, located in a General Hospital), processed by a custom-made IA software, and, in case of necessity, a health warning will be sent to all the interconnected platforms, independently to their location.

Topics

Who is involved

OrganisationCityCountryRole
Libelium Comunicaciones Distribuidas SLZaragozaSpainCoordinator
Institut National De Recherche Biomedicale Du ZaireKinshasa GombeCDParticipant
Bridg OuTallinEstoniaParticipant
Medtronic Iberica SAMadridSpainParticipant
Universidad Complutense De MadridMadridSpainParticipant
Universidad De GranadaGranadaSpainParticipant
University of GhanaAccraGhanaParticipant
Universita Campus Bio Medico Di RomaRomaItalyParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI